Dr. Alsubaie’s research career started as early as medical school. After joining the Mayo Clinic as a Research Trainee he was soon promoted to the title of Research Fellow after winning the Obaid’s Vascularized Composite Allograft Award in addition to a grant of $50,000 to conduct research in the field of face transplantation. This particular research endeavor was conducted under the supervision of Professor Samir Mardini, his Mentor and the current chair of the Division of Plastic Surgery at Mayo Clinic. This research subsequently served as the foundation for the first face transplant operation at the Mayo Clinic. This surgery was performed by Dr. Mardini and his team. National and international media covered this outstanding advancement in the field of plastic and reconstructive surgery.
During his time as a research fellow, Dr. Alsubaie completed a Certificate Program in Clinical and Translational Science at the Mayo Graduate School. His work titled “Prophylactic Antibiotics and Infection Rate in Rhinoplasty and Septoplasty: A Systematic Review and Meta-Analysis of Randomized Control Trials,” shed light on the use of antibiotics in nose surgeries.
In addition to his contributions on face transplantation-focused research, Dr. Alsubaie also worked in the field of Pediatric and Craniofacial Plastic Surgery. He has introduced virtual surgery using computer-assisted design (CAD)/computer-assisted manufacturing (CAM) techniques to expedite surgical planning and operation on children with skull deformities. This work was considered one of the first reports to introduce this novel technology in the field of craniofacial surgery, and it was published in the prestigious Journal of Plastic, Reconstructive, and Aesthetic Surgery (JPRAS). He later presented that work at the highly regarded Mayo Brothers Young Investigator Research Symposium.
Dr. Alsubaie continues to excel in research during residency. His work titled “Outcomes Analysis of Goldilocks Mastectomy and Breast Reconstruction: A Single Institution Experience,” which was published in the Journal of Surgical Oncology provides an option for breast reconstruction for patients who are not suitable for implant-based breast reconstruction. This work is significant , considering that breast cancer is the most common cancer in women. Furthermore, plastic surgeons are always attempting to create novel therapies and reconstruction options for patients following their extensive surgeries for breast cancer treatment.
In a letter to the editor that was published in the esteemed Plastic and Reconstructive Surgery (PRS), Dr. Alsubaie and his colleagues were the first to suggest using the term “creation” rather than “reconstruction” when describing gender-affirming surgery; this contribution shed light on the significance of this new era in the field of Plastic and Reconstructive Surgery.
Additionally, Dr. Alsubaie is involved in quality improvement research. His work titled, “Reducing Retained Corneal Shields in Craniofacial Surgery” was accepted for poster presentation at Mayo Clinic 2018 Quality Conference. The work proposes safety and preventive measures to reduce and eliminate accidental eye injuries during craniofacial surgery for both children and adults.
Recently, Dr. Alsubaie was invited as an expert to write a commentary on circumferential arm liposuction and along with his mentor Joseph P. Hunstad discussed the novel technique of four-positioned circumferential arm liposuction. He also was invited again to write another commentary on the novel use of tranexamic acid (TXA) to decrease blood loss and bruising in body contouring surgeries.